siRNA treatment decreases triglycerides in individuals with uncommon health condition

.STUDY HIGHLIGHT.19 September 2024.

Plozasiran lowered triglyceride amounts by 80% as well as decreased the danger of pancreatitis in clients along with consistent chylomicronemia, along with or without a genetic medical diagnosis.